Cargando…
Treatment of mantle cell lymphoma in Asia: a consensus paper from the Asian Lymphoma Study Group
BACKGROUND: Mantle cell lymphoma (MCL) is a B cell malignancy that can be aggressive and with a poor prognosis; the clinical course is heterogeneous. The epidemiology of MCL in Asia is not well documented but appears to comprise 2–6% of all lymphoma cases based on available data, with variation obse...
Autores principales: | Yoon, Dok Hyun, Cao, Junning, Chen, Tsai-Yun, Izutsu, Koji, Kim, Seok Jin, Kwong, Yok Lam, Lin, Tong Yu, Thye, Lim Soon, Xu, Bing, Yang, Deok Hwan, Kim, Won Seog |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7079508/ https://www.ncbi.nlm.nih.gov/pubmed/32183871 http://dx.doi.org/10.1186/s13045-020-00855-9 |
Ejemplares similares
-
Extranodal natural killer/T-cell lymphoma involving the gastrointestinal tract: analysis of clinical features and outcomes from the Asia Lymphoma study group
por: Kim, Seok Jin, et al.
Publicado: (2013) -
Darinaparsin in patients with relapsed or refractory peripheral T-cell lymphoma: results of an Asian phase 2 study
por: Kim, Won-Seog, et al.
Publicado: (2023) -
Treatment patterns and outcomes of older patients with mantle cell lymphoma in an Asian population
por: Yang, Xinyi, et al.
Publicado: (2021) -
Methylation of miR-155-3p in mantle cell lymphoma and other non-Hodgkin's lymphomas
por: Yim, Rita Lh, et al.
Publicado: (2014) -
Treatment Outcomes and Survival Patterns of Asian Patients With Relapsed/Refractory Mantle Cell Lymphoma
por: Tan, Jing Yuan, et al.
Publicado: (2021)